ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tachykinin Receptor 1 Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-18J8809
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Tachykinin Receptor 1 Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global Tachykinin Receptor 1 Antibody Market Research Report 2025

Code: QYRE-Auto-18J8809
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
LSBio
Advanced Targeting Solutions
United States Biological
Everest Biotech
NSJ Bioreagents
ProSci
Cusabio
FineTest
GeneTex
Santa Cruz Biotechnology
Merck
Atlas Antibodies
Proteintech
Boster Biological Technology

Tachykinin Receptor 1 Antibody Market

The global market for Tachykinin Receptor 1 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Tachykinin Receptor 1 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tachykinin Receptor 1 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Tachykinin Receptor 1 Antibody in Flow Cytometry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Tachykinin Receptor 1 Antibody include LSBio, Advanced Targeting Solutions, United States Biological, Everest Biotech, NSJ Bioreagents, ProSci, Cusabio, FineTest, GeneTex, Santa Cruz Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tachykinin Receptor 1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tachykinin Receptor 1 Antibody.
The Tachykinin Receptor 1 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tachykinin Receptor 1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tachykinin Receptor 1 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tachykinin Receptor 1 Antibody Market Report

Report Metric Details
Report Name Tachykinin Receptor 1 Antibody Market
Segment by Type
  • Polyclonal
  • Monoclonal
Segment by Application
  • Flow Cytometry
  • Immunocytochemistry
  • Immunofluorescence
  • Western Blot
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company LSBio, Advanced Targeting Solutions, United States Biological, Everest Biotech, NSJ Bioreagents, ProSci, Cusabio, FineTest, GeneTex, Santa Cruz Biotechnology, Merck, Atlas Antibodies, Proteintech, Boster Biological Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tachykinin Receptor 1 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tachykinin Receptor 1 Antibody Market report?

Ans: The main players in the Tachykinin Receptor 1 Antibody Market are LSBio, Advanced Targeting Solutions, United States Biological, Everest Biotech, NSJ Bioreagents, ProSci, Cusabio, FineTest, GeneTex, Santa Cruz Biotechnology, Merck, Atlas Antibodies, Proteintech, Boster Biological Technology

What are the Application segmentation covered in the Tachykinin Receptor 1 Antibody Market report?

Ans: The Applications covered in the Tachykinin Receptor 1 Antibody Market report are Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot, Others

What are the Type segmentation covered in the Tachykinin Receptor 1 Antibody Market report?

Ans: The Types covered in the Tachykinin Receptor 1 Antibody Market report are Polyclonal, Monoclonal

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tachykinin Receptor 1 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global Tachykinin Receptor 1 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Flow Cytometry
1.3.3 Immunocytochemistry
1.3.4 Immunofluorescence
1.3.5 Western Blot
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tachykinin Receptor 1 Antibody Market Perspective (2020-2031)
2.2 Global Tachykinin Receptor 1 Antibody Growth Trends by Region
2.2.1 Global Tachykinin Receptor 1 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tachykinin Receptor 1 Antibody Historic Market Size by Region (2020-2025)
2.2.3 Tachykinin Receptor 1 Antibody Forecasted Market Size by Region (2026-2031)
2.3 Tachykinin Receptor 1 Antibody Market Dynamics
2.3.1 Tachykinin Receptor 1 Antibody Industry Trends
2.3.2 Tachykinin Receptor 1 Antibody Market Drivers
2.3.3 Tachykinin Receptor 1 Antibody Market Challenges
2.3.4 Tachykinin Receptor 1 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tachykinin Receptor 1 Antibody Players by Revenue
3.1.1 Global Top Tachykinin Receptor 1 Antibody Players by Revenue (2020-2025)
3.1.2 Global Tachykinin Receptor 1 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Tachykinin Receptor 1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tachykinin Receptor 1 Antibody Revenue
3.4 Global Tachykinin Receptor 1 Antibody Market Concentration Ratio
3.4.1 Global Tachykinin Receptor 1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tachykinin Receptor 1 Antibody Revenue in 2024
3.5 Global Key Players of Tachykinin Receptor 1 Antibody Head office and Area Served
3.6 Global Key Players of Tachykinin Receptor 1 Antibody, Product and Application
3.7 Global Key Players of Tachykinin Receptor 1 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tachykinin Receptor 1 Antibody Breakdown Data by Type
4.1 Global Tachykinin Receptor 1 Antibody Historic Market Size by Type (2020-2025)
4.2 Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Type (2026-2031)
5 Tachykinin Receptor 1 Antibody Breakdown Data by Application
5.1 Global Tachykinin Receptor 1 Antibody Historic Market Size by Application (2020-2025)
5.2 Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tachykinin Receptor 1 Antibody Market Size (2020-2031)
6.2 North America Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025)
6.4 North America Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tachykinin Receptor 1 Antibody Market Size (2020-2031)
7.2 Europe Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025)
7.4 Europe Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size (2020-2031)
8.2 Asia-Pacific Tachykinin Receptor 1 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tachykinin Receptor 1 Antibody Market Size (2020-2031)
9.2 Latin America Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025)
9.4 Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size (2020-2031)
10.2 Middle East & Africa Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LSBio
11.1.1 LSBio Company Details
11.1.2 LSBio Business Overview
11.1.3 LSBio Tachykinin Receptor 1 Antibody Introduction
11.1.4 LSBio Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.1.5 LSBio Recent Development
11.2 Advanced Targeting Solutions
11.2.1 Advanced Targeting Solutions Company Details
11.2.2 Advanced Targeting Solutions Business Overview
11.2.3 Advanced Targeting Solutions Tachykinin Receptor 1 Antibody Introduction
11.2.4 Advanced Targeting Solutions Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.2.5 Advanced Targeting Solutions Recent Development
11.3 United States Biological
11.3.1 United States Biological Company Details
11.3.2 United States Biological Business Overview
11.3.3 United States Biological Tachykinin Receptor 1 Antibody Introduction
11.3.4 United States Biological Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.3.5 United States Biological Recent Development
11.4 Everest Biotech
11.4.1 Everest Biotech Company Details
11.4.2 Everest Biotech Business Overview
11.4.3 Everest Biotech Tachykinin Receptor 1 Antibody Introduction
11.4.4 Everest Biotech Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.4.5 Everest Biotech Recent Development
11.5 NSJ Bioreagents
11.5.1 NSJ Bioreagents Company Details
11.5.2 NSJ Bioreagents Business Overview
11.5.3 NSJ Bioreagents Tachykinin Receptor 1 Antibody Introduction
11.5.4 NSJ Bioreagents Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.5.5 NSJ Bioreagents Recent Development
11.6 ProSci
11.6.1 ProSci Company Details
11.6.2 ProSci Business Overview
11.6.3 ProSci Tachykinin Receptor 1 Antibody Introduction
11.6.4 ProSci Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.6.5 ProSci Recent Development
11.7 Cusabio
11.7.1 Cusabio Company Details
11.7.2 Cusabio Business Overview
11.7.3 Cusabio Tachykinin Receptor 1 Antibody Introduction
11.7.4 Cusabio Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.7.5 Cusabio Recent Development
11.8 FineTest
11.8.1 FineTest Company Details
11.8.2 FineTest Business Overview
11.8.3 FineTest Tachykinin Receptor 1 Antibody Introduction
11.8.4 FineTest Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.8.5 FineTest Recent Development
11.9 GeneTex
11.9.1 GeneTex Company Details
11.9.2 GeneTex Business Overview
11.9.3 GeneTex Tachykinin Receptor 1 Antibody Introduction
11.9.4 GeneTex Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.9.5 GeneTex Recent Development
11.10 Santa Cruz Biotechnology
11.10.1 Santa Cruz Biotechnology Company Details
11.10.2 Santa Cruz Biotechnology Business Overview
11.10.3 Santa Cruz Biotechnology Tachykinin Receptor 1 Antibody Introduction
11.10.4 Santa Cruz Biotechnology Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.10.5 Santa Cruz Biotechnology Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Tachykinin Receptor 1 Antibody Introduction
11.11.4 Merck Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Atlas Antibodies
11.12.1 Atlas Antibodies Company Details
11.12.2 Atlas Antibodies Business Overview
11.12.3 Atlas Antibodies Tachykinin Receptor 1 Antibody Introduction
11.12.4 Atlas Antibodies Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.12.5 Atlas Antibodies Recent Development
11.13 Proteintech
11.13.1 Proteintech Company Details
11.13.2 Proteintech Business Overview
11.13.3 Proteintech Tachykinin Receptor 1 Antibody Introduction
11.13.4 Proteintech Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.13.5 Proteintech Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Details
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Tachykinin Receptor 1 Antibody Introduction
11.14.4 Boster Biological Technology Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025)
11.14.5 Boster Biological Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
LSBio
Advanced Targeting Solutions
United States Biological
Everest Biotech
NSJ Bioreagents
ProSci
Cusabio
FineTest
GeneTex
Santa Cruz Biotechnology
Merck
Atlas Antibodies
Proteintech
Boster Biological Technology
List of Tables
 Table 1. Global Tachykinin Receptor 1 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polyclonal
 Table 3. Key Players of Monoclonal
 Table 4. Global Tachykinin Receptor 1 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Tachykinin Receptor 1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Tachykinin Receptor 1 Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Tachykinin Receptor 1 Antibody Market Share by Region (2020-2025)
 Table 8. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Tachykinin Receptor 1 Antibody Market Share by Region (2026-2031)
 Table 10. Tachykinin Receptor 1 Antibody Market Trends
 Table 11. Tachykinin Receptor 1 Antibody Market Drivers
 Table 12. Tachykinin Receptor 1 Antibody Market Challenges
 Table 13. Tachykinin Receptor 1 Antibody Market Restraints
 Table 14. Global Tachykinin Receptor 1 Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Tachykinin Receptor 1 Antibody Market Share by Players (2020-2025)
 Table 16. Global Top Tachykinin Receptor 1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tachykinin Receptor 1 Antibody as of 2024)
 Table 17. Ranking of Global Top Tachykinin Receptor 1 Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Tachykinin Receptor 1 Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Tachykinin Receptor 1 Antibody, Headquarters and Area Served
 Table 20. Global Key Players of Tachykinin Receptor 1 Antibody, Product and Application
 Table 21. Global Key Players of Tachykinin Receptor 1 Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Tachykinin Receptor 1 Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global Tachykinin Receptor 1 Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. LSBio Company Details
 Table 47. LSBio Business Overview
 Table 48. LSBio Tachykinin Receptor 1 Antibody Product
 Table 49. LSBio Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 50. LSBio Recent Development
 Table 51. Advanced Targeting Solutions Company Details
 Table 52. Advanced Targeting Solutions Business Overview
 Table 53. Advanced Targeting Solutions Tachykinin Receptor 1 Antibody Product
 Table 54. Advanced Targeting Solutions Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 55. Advanced Targeting Solutions Recent Development
 Table 56. United States Biological Company Details
 Table 57. United States Biological Business Overview
 Table 58. United States Biological Tachykinin Receptor 1 Antibody Product
 Table 59. United States Biological Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 60. United States Biological Recent Development
 Table 61. Everest Biotech Company Details
 Table 62. Everest Biotech Business Overview
 Table 63. Everest Biotech Tachykinin Receptor 1 Antibody Product
 Table 64. Everest Biotech Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 65. Everest Biotech Recent Development
 Table 66. NSJ Bioreagents Company Details
 Table 67. NSJ Bioreagents Business Overview
 Table 68. NSJ Bioreagents Tachykinin Receptor 1 Antibody Product
 Table 69. NSJ Bioreagents Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 70. NSJ Bioreagents Recent Development
 Table 71. ProSci Company Details
 Table 72. ProSci Business Overview
 Table 73. ProSci Tachykinin Receptor 1 Antibody Product
 Table 74. ProSci Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 75. ProSci Recent Development
 Table 76. Cusabio Company Details
 Table 77. Cusabio Business Overview
 Table 78. Cusabio Tachykinin Receptor 1 Antibody Product
 Table 79. Cusabio Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 80. Cusabio Recent Development
 Table 81. FineTest Company Details
 Table 82. FineTest Business Overview
 Table 83. FineTest Tachykinin Receptor 1 Antibody Product
 Table 84. FineTest Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 85. FineTest Recent Development
 Table 86. GeneTex Company Details
 Table 87. GeneTex Business Overview
 Table 88. GeneTex Tachykinin Receptor 1 Antibody Product
 Table 89. GeneTex Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 90. GeneTex Recent Development
 Table 91. Santa Cruz Biotechnology Company Details
 Table 92. Santa Cruz Biotechnology Business Overview
 Table 93. Santa Cruz Biotechnology Tachykinin Receptor 1 Antibody Product
 Table 94. Santa Cruz Biotechnology Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 95. Santa Cruz Biotechnology Recent Development
 Table 96. Merck Company Details
 Table 97. Merck Business Overview
 Table 98. Merck Tachykinin Receptor 1 Antibody Product
 Table 99. Merck Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 100. Merck Recent Development
 Table 101. Atlas Antibodies Company Details
 Table 102. Atlas Antibodies Business Overview
 Table 103. Atlas Antibodies Tachykinin Receptor 1 Antibody Product
 Table 104. Atlas Antibodies Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 105. Atlas Antibodies Recent Development
 Table 106. Proteintech Company Details
 Table 107. Proteintech Business Overview
 Table 108. Proteintech Tachykinin Receptor 1 Antibody Product
 Table 109. Proteintech Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 110. Proteintech Recent Development
 Table 111. Boster Biological Technology Company Details
 Table 112. Boster Biological Technology Business Overview
 Table 113. Boster Biological Technology Tachykinin Receptor 1 Antibody Product
 Table 114. Boster Biological Technology Revenue in Tachykinin Receptor 1 Antibody Business (2020-2025) & (US$ Million)
 Table 115. Boster Biological Technology Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Tachykinin Receptor 1 Antibody Picture
 Figure 2. Global Tachykinin Receptor 1 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tachykinin Receptor 1 Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Polyclonal Features
 Figure 5. Monoclonal Features
 Figure 6. Global Tachykinin Receptor 1 Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tachykinin Receptor 1 Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Flow Cytometry Case Studies
 Figure 9. Immunocytochemistry Case Studies
 Figure 10. Immunofluorescence Case Studies
 Figure 11. Western Blot Case Studies
 Figure 12. Others Case Studies
 Figure 13. Tachykinin Receptor 1 Antibody Report Years Considered
 Figure 14. Global Tachykinin Receptor 1 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Tachykinin Receptor 1 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Tachykinin Receptor 1 Antibody Market Share by Region: 2024 VS 2031
 Figure 17. Global Tachykinin Receptor 1 Antibody Market Share by Players in 2024
 Figure 18. Global Top Tachykinin Receptor 1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tachykinin Receptor 1 Antibody as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Tachykinin Receptor 1 Antibody Revenue in 2024
 Figure 20. North America Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Tachykinin Receptor 1 Antibody Market Share by Country (2020-2031)
 Figure 22. United States Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Tachykinin Receptor 1 Antibody Market Share by Country (2020-2031)
 Figure 26. Germany Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Tachykinin Receptor 1 Antibody Market Share by Region (2020-2031)
 Figure 34. China Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Tachykinin Receptor 1 Antibody Market Share by Country (2020-2031)
 Figure 42. Mexico Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Tachykinin Receptor 1 Antibody Market Share by Country (2020-2031)
 Figure 46. Turkey Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Tachykinin Receptor 1 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. LSBio Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 50. Advanced Targeting Solutions Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 51. United States Biological Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 52. Everest Biotech Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 53. NSJ Bioreagents Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 54. ProSci Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 55. Cusabio Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 56. FineTest Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 57. GeneTex Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 58. Santa Cruz Biotechnology Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 59. Merck Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 60. Atlas Antibodies Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 61. Proteintech Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 62. Boster Biological Technology Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global KAT8 Antibody Market Research Report 2024
Global ALK 1 Antibody Market Research Report 2024
Global JAG1 Antibody Market Research Report 2024
Global AHSA1 Antibody Market Research Report 2024
Global Erk1 Antibody Market Research Report 2024
Global IHC Antibody Market Research Report 2024
Global Metabotropic Glutamate Receptor 1 Market Research Report 2025
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Research Report 2024
Global Activin Receptor Type 1 Market Research Report 2024
Global KI 67 Antibody Market Research Report 2024
Global Growth Hormone Secretagogue Receptor Type 1 Market Research Report 2024
Global Calcitonin Antibody Market Research Report 2024
Global Antibodies Market Research Report 2024
Global Insulin Like Growth Factor 1 Receptor Market Research Report 2024
Global J Chain Antibody Market Research Report 2024
Global EXT1 Antibody Market Research Report 2025
Global Monoclonal Antibodies Product Market Research Report 2024
Global EGFR Antibody Market Research Report 2024
Global CGRP Monoclonal Antibodies Market Research Report 2024
Global Chimeric Antibody Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions